Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin?

Lucchesi A, Carloni S, De Matteis S, Ghetti M, Musuraca G, Poggiaspalla M, Augello AF, Giordano G, Fattori PP, Martinelli G, Napolitano R.

Br J Haematol. 2019 Dec 2. doi: 10.1111/bjh.16335. [Epub ahead of print]

PMID:
31792942
2.

Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi.

Merli F, Cavallo F, Salvi F, Tucci A, Musuraca G, Nassi L, Merli M, Tani M, Gini G, Ferrari A, Molinari AL, Liberati AM, Conconi A, Matteucci P, Bari A, Scalone R, Ferrero S, Zanni M, Mammi C, Luminari S.

J Geriatr Oncol. 2020 Jan;11(1):37-40. doi: 10.1016/j.jgo.2019.06.020. Epub 2019 Jul 8.

PMID:
31296461
3.

Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL).

Salvi F, Luminari S, Tucci A, Massidda S, Liberati AM, Stelitano C, Zanni M, Re A, Centurioni R, Freilone R, Musuraca G, Nassi L, Patti C, Arcari A, Tani M, Pulsoni A, Pavone V, Volpetti S, Peli A, Evangelista A, Spina M, Ladetto M, Merli F.

Leuk Lymphoma. 2019 Dec;60(12):2890-2898. doi: 10.1080/10428194.2019.1608529. Epub 2019 Jul 8.

PMID:
31282794
4.

The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.

Cox MC, Pelliccia S, Marcheselli L, Battistini R, Arcari A, Borza PA, Patti C, Casaroli I, di Landro F, Di Napoli A, Fabbri F, Caridi M, Tafuri A, Bocci G, Musuraca G.

Invest New Drugs. 2019 Jun;37(3):548-558. doi: 10.1007/s10637-019-00769-5. Epub 2019 Apr 26.

PMID:
31028663
5.

Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.

Broccoli A, Casadei B, Chiappella A, Visco C, Tani M, Cascavilla N, Conconi A, Balzarotti M, Cox MC, Marino D, Goldaniga MC, Marasca R, Tecchio C, Patti C, Musuraca G, Devizzi L, Monaco F, Romano A, Fama A, Zancanella M, Paolini R, Rigacci L, Castellino C, Gaudio F, Argnani L, Zinzani PL.

Oncologist. 2019 Sep;24(9):1246-1252. doi: 10.1634/theoncologist.2018-0603. Epub 2019 Apr 2.

6.

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies.

Ayed AO, Chiappella A, Pederson L, Laplant BR, Congiu AG, Gaidano G, Spina M, Re A, Cavallo F, Musuraca G, Macon WR, Witzig T, Vitolo U, Nowakowski GS.

Blood Cancer J. 2018 Jun 26;8(7):63. doi: 10.1038/s41408-018-0097-0.

7.

Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.

De Matteis S, Molinari C, Abbati G, Rossi T, Napolitano R, Ghetti M, Di Rorà AGL, Musuraca G, Lucchesi A, Rigolin GM, Cuneo A, Calistri D, Fattori PP, Bonafè M, Martinelli G.

J Transl Med. 2018 Jun 20;16(1):172. doi: 10.1186/s12967-018-1545-0.

8.

Very late migration to and retrieval of an Amplatzer patent foramen ovale occlusion device from the abdominal aortic carrefour.

Musuraca G, Agostoni P, Boldi E, Imperadore F, Terraneo C, Broso GP.

J Cardiovasc Med (Hagerstown). 2018 Aug;19(8):459-461. doi: 10.2459/JCM.0000000000000674. No abstract available.

PMID:
29894354
9.

Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.

Storti S, Spina M, Pesce EA, Salvi F, Merli M, Ruffini A, Cabras G, Chiappella A, Angelucci E, Fabbri A, Liberati AM, Tani M, Musuraca G, Molinari A, Petrilli MP, Palladino C, Ciancia R, Ferrario A, Gasbarrino C, Monaco F, Fraticelli V, De Vellis A, Merli F, Luminari S.

Haematologica. 2018 Aug;103(8):1345-1350. doi: 10.3324/haematol.2017.186569. Epub 2018 May 10.

10.

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.

Cuneo A, Follows G, Rigolin GM, Piciocchi A, Tedeschi A, Trentin L, Perez AM, Coscia M, Laurenti L, Musuraca G, Farina L, Delgado AR, Orlandi EM, Galieni P, Mauro FR, Visco C, Amendola A, Billio A, Marasca R, Chiarenza A, Meneghini V, Ilariucci F, Marchetti M, Molica S, Re F, Gaidano G, Gonzalez M, Forconi F, Ciolli S, Cortelezzi A, Montillo M, Smolej L, Schuh A, Eyre TA, Kennedy B, Bowles KM, Vignetti M, de la Serna J, Moreno C, Foà R, Ghia P; GIMEMA, European Research Initiative on CLL (ERIC) and UK CLL forum.

Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

11.

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).

Stefoni V, Pellegrini C, Broccoli A, Baldini L, Tani M, Cencini E, Figuera A, Ansuinelli M, Bernocco E, Cantonetti M, Cox MC, Ballerini F, Rusconi C, Visco C, Arcaini L, Fama A, Marasca R, Volpetti S, Castellino A, Califano C, Cavaliere M, Gini G, Liberati AM, Musuraca G, Lucania A, Ricciuti G, Argnani L, Zinzani PL.

Oncologist. 2018 Sep;23(9):1033-1038. doi: 10.1634/theoncologist.2017-0597. Epub 2018 Apr 19.

12.

Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.

Cox MC, Musuraca G, Battistini R, Casaroli I, Zoli V, Anticoli-Borza P, Arcari A, Naso V, di Landro F, Fabbri F, Tafuri A, Bocci G, Merli F.

Br J Haematol. 2018 Dec;183(5):819-822. doi: 10.1111/bjh.15039. Epub 2017 Nov 28. No abstract available.

PMID:
29193017
13.

Pentoxifylline-Induced Apoptosis in Chronic Lymphocytic Leukemia: New Insights into Molecular Mechanism.

Napolitano R, De Matteis S, Lucchesi A, Carloni S, Cangini D, Musuraca G, Liardo EV, Norata M, Fattori PP.

Mini Rev Med Chem. 2018;18(3):287-294. doi: 10.2174/1389557517666171002162258.

PMID:
28969553
14.

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.

Luminari S, Viel E, Ferreri AJM, Zaja F, Chimienti E, Musuraca G, Tucci A, Balzarotti M, Tani M, Salvi F, Pesce EA, Ferrari A, Liberati AM, Spadea A, Marino D, Bruno-Ventre M, Volpetti S, Bottelli C, Ravaioli E, Merli F, Spina M.

Hematol Oncol. 2018 Feb;36(1):68-75. doi: 10.1002/hon.2425. Epub 2017 May 19.

PMID:
28524259
15.

The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma.

Agostinelli C, Carloni S, Limarzi F, Righi S, Laginestra MA, Musuraca G, Fiorentino M, Napolitano R, Cuneo A, Vergara D, Zinzani PL, Sabattini E, Pileri SA, De Matteis S.

Histopathology. 2017 Jul;71(1):72-80. doi: 10.1111/his.13189. Epub 2017 Apr 11.

PMID:
28208230
16.

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.

Zaja F, Ferrero S, Stelitano C, Ferrari A, Salvi F, Arcari A, Musuraca G, Botto B, Spina M, Cellini C, Patti C, Liberati AM, Minotto C, Pileri SA, Ceccarelli M, Volpetti S, Ferranti A, Drandi D, Montechiarello E, Ladetto M, Carmichael J, Fanin R.

Haematologica. 2017 May;102(5):e203-e206. doi: 10.3324/haematol.2016.154211. Epub 2017 Jan 12. No abstract available.

17.

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

Gentile M, Zirlik K, Ciolli S, Mauro FR, Di Renzo N, Mastrullo L, Angrilli F, Molica S, Tripepi G, Giordano A, Di Raimondo F, Selleri C, Coscia M, Musso M, Orsucci L, Mannina D, Rago A, Giannotta A, Ferrara F, Herishanu Y, Shvidel L, Tadmor T, Scortechini I, Ilariucci F, Murru R, Guarini A, Musuraca G, Mineo G, Vincelli I, Arcari A, Tarantini G, Caparrotti G, Chiarenza A, Levato L, Villa MR, De Paolis MR, Zinzani PL, Polliack A, Morabito F.

Eur J Cancer. 2016 Jun;60:154-65. doi: 10.1016/j.ejca.2016.03.069. Epub 2016 Apr 27.

PMID:
27127905
18.

Coronarographyc detection of double right coronary artery arising from two separated ostia in the right sinus of Valsalva.

Musuraca G, Agostoni P, Terraneo C, Boldi E, Di Matteo I, Centonze M.

Minerva Cardioangiol. 2015 Dec;63(6):589-90. Epub 2015 Sep 15. No abstract available.

PMID:
26373779
19.

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia.

Musuraca G, De Matteis S, Napolitano R, Papayannidis C, Guadagnuolo V, Fabbri F, Cangini D, Ceccolini M, Giannini MB, Lucchesi A, Ronconi S, Mariotti P, Savini P, Tani M, Fattori PP, Guidoboni M, Martinelli G, Zoli W, Amadori D, Carloni S.

J Transl Med. 2015 Jul 15;13:229. doi: 10.1186/s12967-015-0590-1.

20.

Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report.

Lucchesi A, Fattori PP, Ronconi S, Carloni S, Casadei Gardini A, Musuraca G, Napolitano M.

Ann Hematol. 2015 Sep;94(9):1597-8. doi: 10.1007/s00277-015-2415-y. Epub 2015 Jun 9. No abstract available.

PMID:
26051903
21.

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia.

Moreno C, Montillo M, Panayiotidis P, Dimou M, Bloor A, Dupuis J, Schuh A, Norin S, Geisler C, Hillmen P, Doubek M, Trněný M, Obrtlikova P, Laurenti L, Stilgenbauer S, Smolej L, Ghia P, Cymbalista F, Jaeger U, Stamatopoulos K, Stavroyianni N, Carrington P, Zouabi H, Leblond V, Gomez-Garcia JC, Rubio M, Marasca R, Musuraca G, Rigacci L, Farina L, Paolini R, Pospisilova S, Kimby E, Bradley C, Montserrat E.

Haematologica. 2015 Apr;100(4):511-6. doi: 10.3324/haematol.2014.118158. Epub 2015 Jan 16.

22.

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.

Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, Valeri N, Calore F, Sampath D, Fanini F, Vannini I, Musuraca G, Dell'Aquila M, Alder H, Davuluri RV, Rassenti LZ, Negrini M, Nakamura T, Amadori D, Kay NE, Rai KR, Keating MJ, Kipps TJ, Calin GA, Croce CM.

JAMA. 2011 Jan 5;305(1):59-67. doi: 10.1001/jama.2010.1919.

23.

Prolonged 18FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd-G).

Musuraca G, Fattori PP, Ceccolini M, Cangini D, Giannini MB, Ronconi S, Matteucci F, Asioli S, Amadori D.

Am J Hematol. 2011 Jan;86(1):79-80. doi: 10.1002/ajh.21869. Epub 2010 Oct 15.

24.

Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients.

Zinzani PL, Broccoli A, Stefoni V, Musuraca G, Abruzzese E, De Renzo A, Cantonetti M, Bacci F, Baccarani M, Pileri SA.

Cancer. 2010 Dec 15;116(24):5667-75. doi: 10.1002/cncr.25307. Epub 2010 Aug 24.

25.

Pheochromocytoma mimicking a non-ST elevation acute myocardial infarction.

Musuraca G, Imperadore F, Terraneo C, Vaccarini C, Prati D, Centonze M, Vergara G.

Cardiol J. 2009;16(4):355-7.

26.

Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma.

Zinzani PL, Stefoni V, Tani M, Fanti S, Musuraca G, Castellucci P, Marchi E, Fina M, Ambrosini V, Pellegrini C, Alinari L, Derenzini E, Montini G, Broccoli A, Bacci F, Pileri S, Baccarani M.

J Clin Oncol. 2009 Apr 10;27(11):1781-7. doi: 10.1200/JCO.2008.16.1513. Epub 2009 Mar 9.

PMID:
19273712
27.

Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.

Derenzini E, Musuraca G, Fanti S, Stefoni V, Tani M, Alinari L, Venturini F, Gandolfi L, Baccarani M, Zinzani PL.

Cancer. 2008 Nov 1;113(9):2496-503. doi: 10.1002/cncr.23861.

28.

Thrombolytic treatment of acute myocardial infarction in the presence of ventricular paced rhythm.

Imperadore F, Musuraca G, Terraneo C, Cemin C, Cirrincione C, Prati D, Vergara G.

Minerva Cardioangiol. 2008 Aug;56(4):435-9.

PMID:
18614988
29.

Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).

Zinzani PL, Tani M, Pulsoni A, Gobbi M, Perotti A, De Luca S, Fabbri A, Zaccaria A, Voso MT, Fattori P, Guardigni L, Ronconi S, Cabras MG, Rigacci L, De Renzo A, Marchi E, Stefoni V, Fina M, Pellegrini C, Musuraca G, Derenzini E, Pileri S, Fanti S, Piccaluga PP, Baccarani M.

Lancet Oncol. 2008 Apr;9(4):352-8. doi: 10.1016/S1470-2045(08)70039-1. Epub 2008 Mar 14.

PMID:
18342572
30.

A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.

Zinzani PL, Tani M, Fanti S, Stefoni V, Musuraca G, Castellucci P, Marchi E, Farsad M, Fina M, Pellegrini C, Alinari L, Derenzini E, de Vivo A, Bacci F, Pileri S, Baccarani M.

Ann Oncol. 2008 Apr;19(4):769-73. doi: 10.1093/annonc/mdm560. Epub 2008 Feb 25.

31.

A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.

Zinzani PL, Tani M, Fanti S, Stefoni V, Musuraca G, Vitolo U, Perrotti A, Fina M, Derenzini E, Baccarani M.

Cancer. 2008 Feb 15;112(4):856-62. doi: 10.1002/cncr.23236.

32.

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly.

Fina M, Tani M, Stefoni V, Musuraca G, Marchi E, Pellegrini C, Alinari L, Derenzini E, Bacci F, Pileri S, Baccarani M, Zinzani PL.

Leuk Lymphoma. 2007 Nov;48(11):2167-71.

PMID:
17990178
33.

Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma.

Zinzani PL, Musuraca G, Tani M, Stefoni V, Marchi E, Fina M, Pellegrini C, Alinari L, Derenzini E, de Vivo A, Sabattini E, Pileri S, Baccarani M.

J Clin Oncol. 2007 Sep 20;25(27):4293-7. Epub 2007 Aug 20.

PMID:
17709797
34.

Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.

Zinzani PL, Tani M, Trisolini R, Fanti S, Stefoni V, Alifano M, Castellucci P, Musuraca G, Dalpiaz G, Alinari L, Marchi E, Fina M, Pellegrini C, Farsad M, Cancellieri A, Busca A, Canini R, Pileri S, Baccarani M, Boaron M.

Haematologica. 2007 Jun;92(6):771-7.

35.

Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma.

Zinzani PL, Musuraca G, Alinari L, Fanti S, Tani M, Stefoni V, Marchi E, Fina M, Pellegrini C, Castellucci P, Farsad M, Baccarani M.

Clin Lymphoma Myeloma. 2007 Jan;7(4):291-5.

PMID:
17324337
36.

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.

Zinzani PL, Tani M, Fanti S, Alinari L, Musuraca G, Marchi E, Stefoni V, Castellucci P, Fina M, Farshad M, Pileri S, Baccarani M.

Ann Oncol. 2006 Aug;17(8):1296-300. Epub 2006 Jun 9.

PMID:
16766583
37.

Electrocardiographic abnormalities mimicking myocardial infarction in a patient with intracranial haemorrhage: a possible pitfall for prehospital thrombolysis.

Musuraca G, Imperadore F, Cemin C, Terraneo C, Vaccarini C, De Girolamo PG, Vergara G.

J Cardiovasc Med (Hagerstown). 2006 Jun;7(6):434-7.

PMID:
16721208
38.

Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas.

Stefoni V, Alinari L, Musuraca G, Tani M, Marchi E, Gabriele A, Fina M, Pileri S, Baccarani M, Zinzani PL.

Leuk Lymphoma. 2005 Dec;46(12):1839-41. No abstract available.

PMID:
16263591
39.

Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma.

Alinari L, Musuraca G, Tani M, Stefoni V, Gabriele A, Marchi E, Fina M, De Vivo A, Pileri S, Baccarani M, Zinzani PL.

Leuk Lymphoma. 2005 Oct;46(10):1437-40.

PMID:
16252433
40.

Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.

Zinzani PL, Dirnhofer S, Sabattini E, Alinari L, Piccaluga PP, Stefoni V, Tani M, Musuraca G, Marchi E, Falini B, Baccarani M, Pileri SA.

Haematologica. 2005 Mar;90(3):341-7.

41.

Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.

Zinzani PL, Fanti S, Battista G, Tani M, Castellucci P, Stefoni V, Alinari L, Farsad M, Musuraca G, Gabriele A, Marchi E, Nanni C, Canini R, Monetti N, Baccarani M.

Br J Cancer. 2004 Aug 31;91(5):850-4.

42.

Successful treatment of post-exertion acute myocardial infarction by primary angioplasty and stenting in a patient with antiphospholipid antibody syndrome.

Musuraca G, Imperadore F, Terraneo C, De Girolamo P, Cemin C, Bonmassari R, Vergara G.

Blood Coagul Fibrinolysis. 2004 Jan;15(1):95-8.

PMID:
15166950
43.

Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.

Zinzani PL, Stefoni V, Musuraca G, Tani M, Alinari L, Gabriele A, Marchi E, Pileri S, Baccarani M.

Cancer. 2004 May 15;100(10):2190-4.

44.

[Type A acute aortic dissection presenting as mental status confusion: is it an atypically really uncommon presentation?].

Imperadore F, Morani G, Tilotta F, Musuraca G, Cemin C, De Girolamo P, Vergara G.

Ital Heart J Suppl. 2004 Mar;5(3):221-4. Italian.

PMID:
15116869
45.

High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience.

Zinzani PL, Tani M, Gabriele A, Gherlinzoni F, De Vivo A, Ricci P, Bandini G, Lemoli RM, Motta MR, Rizzi S, Guidice V, Zompatori M, Stefoni V, Alinari L, Musuraca G, Marchi E, Bassi S, Conte R, Pileri S, Tura S, Baccarani M.

Leuk Lymphoma. 2004 Feb;45(2):321-6.

PMID:
15101718
46.

Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.

Zinzani PL, Tani M, Marchi E, Stefoni V, Alinari L, Musuraca G, Gabriele A, Pileri S, Baccarani M.

Haematologica. 2004 Mar;89(3):309-13.

47.

Cardiac tamponade mimicking ventricular rupture after thrombolysis for acute myocardial infarction.

Imperadore F, Spagnolli W, Martinelli L, Musuraca G, De Girolamo P, Maines M, Vergara G.

Minerva Cardioangiol. 2003 Aug;51(4):417-8. No abstract available.

PMID:
12900724
48.

Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients.

Zinzani PL, Tani M, Gabriele A, Poletti V, Stefoni V, Alinari L, Musuraca G, Bonifazi F, Pileri S, Tura S, Baccarani M.

Leuk Lymphoma. 2003 May;44(5):821-4.

PMID:
12802920
49.

High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience.

Zinzani PL, Tani M, Gabriele A, Gherlinzoni F, de Vivo A, Ricci P, Bandini G, Lemoli RM, Motta MR, Rizzi S, Giudice V, Zompatori M, Stefoni V, Alinari L, Musuraca G, Bassi S, Conte R, Pileri S, Tura S, Baccarani M.

Haematologica. 2003 May;88(5):522-8.

Supplemental Content

Loading ...
Support Center